PMC:7265874 / 5510-5749
Annnotations
LitCovid-PD-MONDO
{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T59","span":{"begin":156,"end":162},"obj":"Disease"}],"attributes":[{"id":"A59","pred":"mondo_id","subj":"T59","obj":"http://purl.obolibrary.org/obo/MONDO_0004992"}],"text":" IPA is notoriously difficult, especially in the ICU. In the absence of host factors, as defined by the European Organisation for Research and Treatment of Cancer (EORTC) diagnostic criteria, invasive or high-risk diagnostics (biopsy, CT s"}
LitCovid-PD-CLO
{"project":"LitCovid-PD-CLO","denotations":[{"id":"T47","span":{"begin":113,"end":125},"obj":"http://purl.obolibrary.org/obo/OBI_0000245"}],"text":" IPA is notoriously difficult, especially in the ICU. In the absence of host factors, as defined by the European Organisation for Research and Treatment of Cancer (EORTC) diagnostic criteria, invasive or high-risk diagnostics (biopsy, CT s"}
LitCovid-PD-CHEBI
{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T67","span":{"begin":1,"end":4},"obj":"Chemical"}],"attributes":[{"id":"A67","pred":"chebi_id","subj":"T67","obj":"http://purl.obolibrary.org/obo/CHEBI_17824"},{"id":"A68","pred":"chebi_id","subj":"T67","obj":"http://purl.obolibrary.org/obo/CHEBI_30802"}],"text":" IPA is notoriously difficult, especially in the ICU. In the absence of host factors, as defined by the European Organisation for Research and Treatment of Cancer (EORTC) diagnostic criteria, invasive or high-risk diagnostics (biopsy, CT s"}
LitCovid-PD-HP
{"project":"LitCovid-PD-HP","denotations":[{"id":"T35","span":{"begin":1,"end":4},"obj":"Phenotype"},{"id":"T36","span":{"begin":156,"end":162},"obj":"Phenotype"}],"attributes":[{"id":"A35","pred":"hp_id","subj":"T35","obj":"http://purl.obolibrary.org/obo/HP_0020103"},{"id":"A36","pred":"hp_id","subj":"T36","obj":"http://purl.obolibrary.org/obo/HP_0002664"}],"text":" IPA is notoriously difficult, especially in the ICU. In the absence of host factors, as defined by the European Organisation for Research and Treatment of Cancer (EORTC) diagnostic criteria, invasive or high-risk diagnostics (biopsy, CT s"}
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"160","span":{"begin":156,"end":162},"obj":"Disease"}],"attributes":[{"id":"A160","pred":"tao:has_database_id","subj":"160","obj":"MESH:D009369"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":" IPA is notoriously difficult, especially in the ICU. In the absence of host factors, as defined by the European Organisation for Research and Treatment of Cancer (EORTC) diagnostic criteria, invasive or high-risk diagnostics (biopsy, CT s"}